Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Pear Therapeutics, Inc. - Class A Common Stock
(NQ:
PEAR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pear Therapeutics, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Pear Presents Interim Real-World Data Showing Significant Reductions in Symptoms of Chronic Insomnia, Anxiety and Depression with Somryst® at SLEEP 2022
June 08, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
95 Biggest Movers From Yesterday
↗
June 07, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) shares gained 100.4% to close at $4.75 on Monday after the FDA granted clearance for the company's pūrgo technology, classifying it as a class II...
Via
Benzinga
Mid-Afternoon Market Update: Dow Turns Lower; DiDi Global Shares Surge
↗
June 06, 2022
U.S. stocks pared gains, with the Dow Jones turning lower toward the end of trading on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 06, 2022
Via
Benzinga
Mid-Day Market Update: Nasdaq Rises 1%; Praxis Precision Medicines Shares Plunge
↗
June 06, 2022
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 1% on Monday.
Via
Benzinga
Pear Therapeutics Announces New Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Using reSET® at Six Months
June 06, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Earnings Scheduled For May 16, 2022
↗
May 16, 2022
Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.
Via
Benzinga
52 Stocks Moving In Monday's Mid-Day Session
↗
June 06, 2022
Gainers DiDi Global Inc. (NYSE: DIDI) jumped 51.4% to $2.80 after the Chinese government said the company can resume adding new users.
Via
Benzinga
Pear Therapeutics to Participate in the Jefferies Healthcare Conference
June 02, 2022
From
Pear Therapeutics, Inc
Via
Business Wire
69 Biggest Movers From Friday
↗
June 06, 2022
Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares climbed 118.4% to close at $74.59 on Friday after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per...
Via
Benzinga
Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting
May 24, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022
May 19, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Chardan Capital Maintains Buy Rating for Pear Therapeutics: Here's What You Need To Know
↗
May 17, 2022
Chardan Capital has decided to maintain its Buy rating of Pear Therapeutics (NASDAQ:PEAR) and lower its price target from $16.00 to $13.00. Shares of Pear Therapeutics are trading up 9.75% over the...
Via
Benzinga
10 Biggest Price Target Changes For Tuesday
↗
May 17, 2022
Citigroup cut the price target on Insulet Corporation (NASDAQ: PODD) from $350 to $310. Insulet shares fell 1.1% to close at $196.91 on Monday.
Via
Benzinga
Pear Therapeutics Reports First Quarter 2022 Financial Results
May 16, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
90 Biggest Movers From Yesterday
↗
May 13, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) surged 70.5% to close at $0.1330 on Thursday after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered...
Via
Benzinga
58 Stocks Moving In Thursday's Mid-Day Session
↗
May 12, 2022
Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Via
Benzinga
Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative
May 12, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
May 11, 2022
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
May 11, 2022
Via
Benzinga
Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference
May 11, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference
May 03, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
90 Biggest Movers From Yesterday
↗
May 10, 2022
Gainers
Via
Benzinga
Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022
May 02, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit
April 18, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain
April 13, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Participate in Upcoming Investor Conferences
April 05, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics Announces Program to Bring Prescription Digital Therapeutics to Patients in Recovery Through a Telehealth Provider Experience
April 04, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
Pear Therapeutics to Participate in Upcoming Investor Event Hosted by Credit Suisse
March 31, 2022
From
Pear Therapeutics, Inc.
Via
Business Wire
51 Biggest Movers From Yesterday
↗
March 31, 2022
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
